Silanediol peptidomimetics. Evaluation of four diastereomeric ACE inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 11, 2004, Pages 2853-2856

  Kim, Jaeseung ^a   Sieburth, Scott McN ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b Temple University   (United States)

Author keywords

ACE; Inhibitor; Protease; Silane

Indexed keywords

ALANINE DERIVATIVE; ALCOHOL DERIVATIVE; CARBON; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KETONE; PEPTIDE DERIVATIVE; PHENYLALANINE DERIVATIVE; SILANE DERIVATIVE; SILANEDIOL; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; IC 50; ISOMER;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIPEPTIDES; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR MIMICRY; PEPTIDYL-DIPEPTIDASE A; SILANES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2342639720     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.03.042     Document Type: Article

References (33)

1. Sieburth S.McN., Nittoli T., Mutahi A.M., Guo L. Angew. Chem., Int. Ed. 37:1998;812-814
2. Mutahi M.w., Nittoli T., Guo L., Sieburth S.McN. J. Am. Chem. Soc. 124:2002;7363-7375
3. Chen C.-A., Sieburth S.McN., Glekas A., Hewitt G.W., Trainor G.L., Erickson-Viitanen S., Garber S.S., Cordova B., Jeffrey S., Klabe R.M. Chem. Biol. 8:2001;1161-1166
4. Kim J., Glekas A., Sieburth S.McN. Bioorg. Med. Chem. Lett. 12:2002;3625-3627
5. Gelb M.H., Svaren J.P., Abeles R.H. Biochemistry. 24:1985;1813-1817
6. Reiter L.A., Martinelli G.J., Reeves L.A., Mitchell P.G. Bioorg. Med. Chem. Lett. 10:2000;1581-1584
7. Teater C., Grobelny D., Galardy R.E. Biochem. Biophys. Res. Commun. 153:1988;773-778
8. Corey J.Y. Patai S., Rappoport Z. The Chemistry of Organic Silicon Compounds. 1989;1-56 John Wiley & Sons, New York
9. Collinsova M., Jiracek J. Curr. Med. Chem. 7:2000;629-647
10. Dive V., Lucet-Levannier K., Georgiadis D., Cotton J., Vassiliou S., Cuniasse P., Yiotakis A. Biochem. Soc. Trans. 28:2000;455-460
11. Cypryk M. J. Organomet. Chem. 545-546:1997;483-493
12. Sefcik J., Rankin S.E., Kirchner S.J., McCormick A.V. J. Non-Cryst. Solids. 258:1999;187-197
13. Almquist R.G., Crase J., Jennings-White C., Meyer R.F., Hoefle M.L., Smith R.D., Essenburg A.D., Kaplan H.R. J. Med. Chem. 25:1982;1292-1299
14. Starr J.M., Whalley L.J. ACE Inhibitors. 1994;Raven, New York
15. Vane J.R. J. Physiol. Pharmacol. 50:1999;489-498
16. Uhlig W. Chem. Ber. 129:1996;733-739
17. White J.D., Kawasaki M. J. Org. Chem. 57:1992;5292-5300
18. Bailey W.F., Punzalan E.R. J. Org. Chem. 55:1990;5404-5406
19. Negishi E.-i., Swanson D.R., Rousset C.J. J. Org. Chem. 55:1990;5406-5409
20. Seebach D., Corey E.J. J. Org. Chem. 40:1975;137-231
21. Ricci A., Degl'Innocenti A. Synthesis. 1989;647-660
22. Brook A.G., Duff J.M., Jones P.F., Davis N.R. J. Am. Chem. Soc. 89:1967;431-434
23. Corey E.J., Seebach D., Freedman R. J. Am. Chem. Soc. 89:1967;434-436
24. Hughes D.L. Org. React. (N.Y.). 42:1992;335-656
25. Still W.C., Kahn M., Mitra A. J. Org. Chem. 43:1978;2923-2925
26. w)=0.0880 (0.1810). This crystal structure will be reported elsewhere
27. Ley S.Y., Norman J., Griffith W.P., Marsden S.P. Synthesis. 1994;639-666
28. Bal B.S., Childers W.E. Jr., Pinnick H.W. Tetrahedron. 37:1981;2091-2096
29. Holmquist B., Bünning P., Riordan J.F. Anal. Biochem. 95:1979;540-548
30. Cushman D.W., Cheung H.S. Biochem. Pharmacol. 20:1971;1637-1648
31. Angiotensin-converting enzyme from rabbit lung (Sigma) and N-[3-(2-furyl)acryloyl]-Phe-Gly-Gly as substrate
32. Tacke R., Linoh H., Ernst L., Moser U., Mutschler E., Sarge S., Cammenga H.K., Lambrecht G. Chem. Ber. 120:1987;1229-1237
33. Natesh R., Schwager S.L.U., Sturrock E.D., Acharya K.R. Nature (London). 421:2003;551-554